Vertex Pharmaceuticals Inc. closed 10.89% short of its 52-week high of $519.88, which the company achieved on November 8th.

Davenport’s Q2 results beat the benchmark as AI winners and infrastructure plays led gains. See how stock discipline and ...

US stocks put in solid gains on Thursday, with the S&P 500 and Nasdaq both settling at new record highs, following a raft of ...

VANCOUVER, BC / ACCESS Newswire / July 17, 2025 / Storm Exploration Inc. (TSXV:STRM) ("Storm" or the "Company") is pleased to announce that the Board of Directors has approved a consolidation of its s ...